KODEX SYNTH-US BIOKODEX SYNTH-US BIOKODEX SYNTH-US BIO

KODEX SYNTH-US BIO

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪14.32 B‬KRW
Fund flows (1Y)
‪−3.04 B‬KRW
Dividend yield (indicated)
Discount/Premium to NAV
−0.3%
Shares outstanding
‪566.00 K‬
Expense ratio
0.25%

About KODEX SYNTH-US BIO


Brand
KODEX
Home page
Inception date
Oct 31, 2013
Index tracked
S&P Biotechnology Select Industry
Replication method
Synthetic
Management style
Passive
Dividend treatment
Capitalizes
Primary advisor
Samsung Asset Management Co., Ltd.
ISIN
KR7185680006
KODEX Synth-US bio mainly focuses on USA's biotechnology companies committed to healthier future.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Biotechnology
Strategy
Equal
Geography
U.S.
Weighting scheme
Equal
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of June 11, 2025
Exposure type
Bonds, Cash & Other
Miscellaneous
Bonds, Cash & Other100.00%
Miscellaneous93.73%
ETF5.81%
Cash0.46%
Stock breakdown by region
100%
North America100.00%
Latin America0.00%
Europe0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows



Frequently Asked Questions


185680 assets under management is ‪14.32 B‬ KRW. It's risen 7.23% over the last month.
185680 fund flows account for ‪−3.04 B‬ KRW (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, 185680 doesn't pay dividends to its holders.
185680 shares are issued by Samsung Life Insurance Co., Ltd. under the brand KODEX. The ETF was launched on Oct 31, 2013, and its management style is Passive.
185680 expense ratio is 0.25% meaning you'd have to pay 0.25% of your investment to help manage the fund.
185680 follows the S&P Biotechnology Select Industry. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
185680 invests in funds.
185680 price has risen by 3.05% over the last month, and its yearly performance shows a −11.39% decrease. See more dynamics on 185680 price chart.
NAV returns, another gauge of an ETF dynamics, showed a −7.71% decrease in three-month performance and has decreased by −7.07% in a year.
185680 trades at a premium (0.28%) meaning the ETF is trading at a higher price than the calculated NAV.